Recent Quotes (30 days)

You have no recent quotes
chg | %

West Pharmaceutical Services Inc.  

(Public, NYSE:WST)   Watch this stock  
Find more results for WST
+0.26 (0.26%)
Nov 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 98.07 - 99.34
52 week 77.97 - 103.36
Open 98.44
Vol / Avg. 199,476.00/433,686.00
Mkt cap 7.35B
P/E 39.39
Div/yield 0.14/0.57
EPS 2.51
Shares 74.25M
Beta 1.14
Inst. own 96%
Feb 14, 2018
Q4 2017 West Pharmaceutical Services Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 16, 2017
West Pharmaceutical Services Inc at Jefferies Global Healthcare Conference - Webcast
Oct 26, 2017
Q3 2017 West Pharmaceutical Services Inc Earnings Release
Oct 26, 2017
Q3 2017 West Pharmaceutical Services Inc Earnings Call - Webcast
Sep 13, 2017
West Pharmaceutical Services Inc at Morgan Stanley Healthcare Conference - Webcast
Sep 7, 2017
West Pharmaceutical Services Inc at Wells Fargo Healthcare Conference - Webcast
Sep 6, 2017
West Pharmaceutical Services Inc at Robert W Baird Gobal Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 12.28% 8.97%
Operating margin 16.05% 13.04%
EBITD margin - 21.13%
Return on average assets 10.40% 7.94%
Return on average equity 15.99% 13.41%
Employees 7,300 -
CDP Score - -


EXTON, PA 19341-1147
United States - Map
+1-610-5942900 (Phone)
+1-800-3459800 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


West Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company's segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.

Officers and directors

Eric Mark Green President, Chief Executive Officer, Director
Age: 47
Bio & Compensation  - Reuters
William J. Federici Chief Financial Officer, Senior Vice President, Treasurer
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Annette F. Favorite Chief Human Resource Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
George Lloyd Miller J.D. Senior Vice President, General Counsel, Corporate Secretary
Age: 62
Bio & Compensation  - Reuters
Karen A. Flynn Senior Vice President and Chief Commercial Officer
Age: 54
Bio & Compensation  - Reuters
David A. Montecalvo Senior Vice President - Global Operations and Supply Chain
Age: 51
Bio & Compensation  - Reuters
Eric Resnick Chief Technology Officer, Vice President
Age: 53
Bio & Compensation  - Reuters
Daniel Malone Vice President, Corporate Controller
Age: 55
Bio & Compensation  - Reuters
Michael A. Anderson Vice President, Treasurer
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Patrick J. Zenner Non-Executive Independent Chairman of the Board
Age: 70
Bio & Compensation  - Reuters